U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta

(Reuters) - The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of Eli Lilly and Co's lung cancer drug Alimta

Reuters August 30, 2019 03:05:29 IST
U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta

US FDA approves Mylan generic of Lilly lung cancer drug Alimta

(Reuters) - The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of Eli Lilly and Co's lung cancer drug Alimta.

Shares of Mylan closed up 3.9% at $19.90 on Thursday.

A tentative approval generally signals that the FDA has signed off on the company's marketing application, but that it cannot sell the medicine until the U.S. patents have expired.

Lilly stands to lose U.S. patent protection on the chemotherapy drug, known generically as pemetrexed, in 2022.

Earlier this month, Lilly won a federal appeals court decision protecting its patent from copycat drugs by Pfizer Inc and India's Dr Reddy's Laboratories Ltd.

Alimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.

(Reporting by Tamara Mathias in Bengaluru; editing by Bill Berkrot)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Government aid, stock gains push U.S. wealth to pre-pandemic levels, Fed says
Business

Government aid, stock gains push U.S. wealth to pre-pandemic levels, Fed says

By Howard Schneider WASHINGTON (Reuters) - A rebounding stock market and massive federal aid payments pushed the net worth of U.S. households back to pre-coronavirus levels in the second quarter, the Federal Reserve reported on Monday, with savings accounts and equity portfolios both rising sharply despite the pandemic

Traders shun risky assets as new lockdowns loom
Business

Traders shun risky assets as new lockdowns loom

By Rodrigo Campos NEW YORK (Reuters) - Stocks across the world hit their lowest in seven weeks and other risk assets sold off on Monday on concerns over renewed lockdown measures in Europe and Britain, as well as the United States' inability to agree on fiscal stimulus that would support millions of unemployed. Oil prices fell nearly 5%, the dollar rallied and an index of emerging market currencies fell by the most in six months. The MSCI world equity index , which tracks shares in 49 countries, touched its lowest since Aug.

Traders shun risky assets as new lockdowns loom; stocks, oil tumble
Business

Traders shun risky assets as new lockdowns loom; stocks, oil tumble

By Rodrigo Campos NEW YORK (Reuters) - Stocks across the world hit their lowest in seven weeks and other risk assets also sold off on Monday on concerns over renewed lockdown measures in Europe and Britain, as well as the United States' inability to agree on fiscal stimulus that would support millions of unemployed. Oil prices fell more than 3%, the dollar rose against a basket of peers and an index of emerging market currencies fell by the most in six months. The MSCI world equity index , which tracks shares in 49 countries, ended at its lowest since Aug